Markus H. Weissbach
Chief Operating Officer at Dignity Sciences Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark O'Neill | M | - |
Dignity Sciences Ltd.
 Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| John Climax | M | 71 |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Josephine Coyle | F | - |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Tom O'Leary | M | - | 23 years | |
| Ronan Lambe | M | 84 |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Alan Cooke | M | 52 |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Jane Hollingsworth | F | 66 |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Mehar S. Manku | M | - |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Leopoldo Giampaolo Zambeletti | M | 55 |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| David Coughlan | M | - |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Gray | M | 69 | 15 years | |
| Michael McGrath | M | - | 12 years | |
| Doris Russi Schurter | F | 68 |
University of Freiburg
| 3 years |
| Harald Kintzel | M | 66 |
University of Freiburg
| 7 years |
| Gerhard Johannes Steiger | M | 66 |
University of Freiburg
| 4 years |
| Johan Michael Bitzer | M | 63 |
University of Freiburg
| 4 years |
| Otmar Debald | M | 69 |
University of Freiburg
| 4 years |
| Otmar D. Wiestler | M | 67 |
University of Freiburg
| 3 years |
| Elizabeth Thiele | F | - | - | |
| Vincent Charlon | M | - |
Hesperion AG
 Hesperion AG Miscellaneous Commercial ServicesCommercial Services Hesperion AG provided clinical development services. The firm focused on establishing clinical development partnerships with medical device, biotech and pharmaceutical companies. The company headquartered in Allschwil, Switzerland, | 8 years |
| Christoph Nicolaus Kossmann | M | 65 |
University of Freiburg
| 3 years |
| Wolfgang Renz | M | 54 |
Hesperion AG
Hesperion AG Miscellaneous Commercial ServicesCommercial Services Hesperion AG provided clinical development services. The firm focused on establishing clinical development partnerships with medical device, biotech and pharmaceutical companies. The company headquartered in Allschwil, Switzerland, | 1 years |
| Winfried Holtermüller | M | 64 |
University of Freiburg
| 4 years |
| Franz Mattmann | M | 75 |
University of Freiburg
| 3 years |
| Eimear Kenny | F | - | - | |
| Stefan Marcinowski | M | 71 |
University of Freiburg
| - |
| Abdallah Ennaji | M | 63 |
Hesperion AG
Hesperion AG Miscellaneous Commercial ServicesCommercial Services Hesperion AG provided clinical development services. The firm focused on establishing clinical development partnerships with medical device, biotech and pharmaceutical companies. The company headquartered in Allschwil, Switzerland, | 6 years |
| Zvezdana Seeger | F | 59 |
University of Freiburg
| 5 years |
| Reinhard Christian Zinkann | M | 64 |
University of Freiburg
| 2 years |
| David Young | M | 71 | 6 years | |
| Christophe Hemmerle | M | 63 |
University of Freiburg
| 2 years |
| Wolfgang Häfele | M | - |
University of Freiburg
| 4 years |
| Doris Schmitt-Landsiedel | M | 71 |
University of Freiburg
| 4 years |
| Jürgen Brokatzky-Geiger | M | 72 |
University of Freiburg
| 3 years |
| Jörg Fischer | M | 65 |
University of Freiburg
| 4 years |
| Thomas Richard Fischer | M | 62 |
University of Freiburg
| 3 years |
| Edward Roberts | M | - | 12 years | |
| Joachim Freiherr von Falkenhausen | M | - |
University of Freiburg
| 3 years |
| Nathalie Riebel | F | - | 10 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 19 | 48.72% |
| Ireland | 17 | 43.59% |
| Switzerland | 3 | 7.69% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Markus H. Weissbach
- Personal Network
